Erenumab in migraine: Indication of considerable added benefit for certain patients

Friday, February 8, 2019 - 14:40 in Health & Medicine

The first drug of a new drug class can reduce the number of headache days if other prophylactic medications have failed or have not been an option.

Read the whole article on Science Daily

More from Science Daily

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net